Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
Huimin Zhang, Chunhong Qin, Changming An, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
Mohammed Fatih Rasul, Bashdar Mahmud Hussen, Abbas Salihi, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 112
Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets
Tamizhini Loganathan, C. George Priya Doss
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 94
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid
Limei Zhang, Hui Jiang, Zixin Zhu, et al.
Talanta (2022) Vol. 243, pp. 123388-123388
Closed Access | Times Cited: 72
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 72
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 71
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 59
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 61
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
Yau-Tuen Chan, Yuanjun Lu, Junyu Wu, et al.
Theranostics (2022) Vol. 12, Iss. 7, pp. 3329-3344
Open Access | Times Cited: 55
Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
Ajaz A. Bhat, Sabah Nisar, Soumi Mukherjee, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 50
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers
Sang-Ryul Cha, Jimin Jang, Sung‐Min Park, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 40
Unlocking the potential of non-coding RNAs in cancer research and therapy
Kalyan Ram Uppaluri, Hima Jyothi Challa, Ashish Gaur, et al.
Translational Oncology (2023) Vol. 35, pp. 101730-101730
Open Access | Times Cited: 34
CRISPR-Cas assisted diagnostics: A broad application biosensing approach
Annalisa Masi, Amina Antonacci, Maria Moccia, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 162, pp. 117028-117028
Open Access | Times Cited: 30
CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities
Jun Zhang, Zai Luo, Zheng Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 1
CRISPR/Cas systems for genomic Editing, biochemical Sensing, Bioanalysis, and diagnostics
Mirza Muhammad Faran Ashraf Baig, Sek Ying Chair, Wai Tong Chien
Microchemical Journal (2025), pp. 112638-112638
Closed Access | Times Cited: 1
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Transdermal microneedle-assisted ultrasound-enhanced CRISPRa system to enable sono-gene therapy for obesity
Shaoyue Li, Jing Yu, Yuting Shen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System
Yared Abate Getahun, Destaw Asfaw Ali, Bihonegn Wodajnew Taye, et al.
Veterinary Medicine Research and Reports (2022) Vol. Volume 13, pp. 173-190
Open Access | Times Cited: 32
Photoactive polymers-decorated Cu-Al layered double hydroxide hexagonal architectures: A potential non-viral vector for photothermal therapy and co-delivery of DOX/pCRISPR
Milad Ashrafizadeh, Ehsan Nazarzadeh Zare‬, Filippo Rossi, et al.
Chemical Engineering Journal (2022) Vol. 448, pp. 137747-137747
Closed Access | Times Cited: 31
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
Prashant Kumar Tiwari, Tin-Hsien Ko, Rajni Dubey, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 20
Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top